Pharma execs will testify before Congress 'one way or another,' US senator says
February 05, 2019 at 11:38 AM EST
Pharmaceutical executives have already declined the Senate Finance Committee's invitation to testify about drug prices. Sen. Ron Wyden float this possibility of issuing a subpoena forcing them to testify.
